Differential requirement for interferon-gamma to restrict the growth of or eliminate some recently identified species of nontuberculous mycobacteria in vivo.

@article{Ehlers2001DifferentialRF,
  title={Differential requirement for interferon-gamma to restrict the growth of or eliminate some recently identified species of nontuberculous mycobacteria in vivo.},
  author={Stefan Ehlers and Ekkehard Richter},
  journal={Clinical and experimental immunology},
  year={2001},
  volume={124 2},
  pages={229-38}
}
In recent years, a number of newly identified species of the genus Mycobacterium (M.) have been isolated from tissues of both immunocompetent and immunocompromised patients, e.g. M. celatum, M. intermedium, M. interjectum, M. bohemicum, M. conspicuum, M. confluentis, M. heidelbergense, M. lentiflavum, and M. branderi. Little is known about their in vivo virulence characteristics and the host factors predisposing to infection with these strains. In an effort to elucidate the pathogenesis of… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990s.

Clinical microbiology reviews • 2003
View 7 Excerpts
Highly Influenced

Infections due to various atypical mycobacteria in a Norwegian multiplex family with dominant interferon-gamma receptor deficiency.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America • 2008
View 3 Excerpts

Similar Papers

Loading similar papers…